Abstract
dc:description.abstractOver the last 20 years, there have been significant advances in the management of portal hypertension, with the introduction of drug therapy and the transjugular intrahepatic portosystemic stent-shunt (TIPSS). This development continues at a strong pace as our understanding of the pathogenesis of portal hypertension deepens. There are 2 aims of this thesis:
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2005
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Tripathi, Dhiraj.
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- http://hdl.handle.net/1842/30855